Author:
Zhou Xin,Chen Zhuo,Bi Xinling
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference55 articles.
1. Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice
2. The European Medicines Agency, The European Commission. Biosimilars in the EU - Information guide for healthcare professionals. Prepared jointly by the European Medicines Agency and the European Commission. ©European Med Agency; 2019. Available from: https://www.ema.europa.eu/en/documents/leaflet/biosimilars-eu-information-guide-healthcare-professionals_en.pdf. Accessed July 26, 2020.
3. U.S. Food & Drug Administration. Biosimilar and Interchangeable Products. Available from: https://www.fda.gov/drugs/biosimilars/biosimilar-and-interchangeable-products#biosimilar. Accessed August 31, 2020.
4. Budget Impact Analysis of An Etanercept Biosimilar for The Treatment of Rheumatoid Arthritis In Europe
5. State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献